| Line item | 2025-10-31 FY | 2024-10-31 FY | 2023-10-31 FY | 2022-10-31 FY | 2021-10-31 FY |
|---|---|---|---|---|---|
| Revenue | – | $3.00K | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | – | – | – | – | – |
| SG&A | – | – | $934.72K | $1.04M | $2.56M |
| Operating Income | -$5.33M | -$254.20K | -$1.27M | -$3.44M | -$3.54M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $347.00 | $1.05K | $2.22K | $4.52K | $4.55K |
| Net Income | -$13.10M | -$168.78K | -$1.25M | -$3.17M | -$2.45M |
| EPS (basic) | -0.2800 | 0.0000 | -0.0400 | -0.0900 | -0.0700 |
| EPS (diluted) | -0.2800 | 0.0000 | -0.0400 | -0.0900 | -0.0700 |
| Shares (diluted) | $47.55M | $47.37M | $35.49M | $34.90M | $33.89M |